Verda Bio seeks to bring scientific expertise to product formulation and dosing of cannabinoid based therapeutics (CBTs). At Verda Bio, we are performing research on CBTs using the latest scientific technology to perform genomic, analytical, and clinical research on CBTs. At Verda Bio, genomic and analytical data will serve as the backbone for CBT development. By combining analytical chemistry, technology, and genomic data, Verda Bio will be able to control for the variability in many cannabis strains and create CBTs (cannabinoid based therapeutics) that selectively and consistently meet the needs of specific patient populations.